JERSEY CITY, N.J., Oct. 12, 2016 /PRNewswire/ -- TrialScope, the global leader in clinical trial transparency and compliance solutions, today announced that Dan Lehman has been appointed to the position of Vice President of Business Development.
Dan joins TrialScope with over sixteen years of sales and sales leadership experience. Most recently, he led sales efforts for complex customer migrations at ViewPoint Construction Software. As Vice President of Business Development, Dan will be responsible for leading and growing the sales team and will drive commercial activities, focusing on identifying and expanding new customer opportunities.
Mike Forgash, TrialScope CEO, noted, “We are thrilled to be able to attract such a talented and proven sales executive as Dan. His experience in managing complex enterprise sales cycles will help us achieve our growth objectives and complements our high-touch engagement methodology. His consultative approach aligns with our goal of providing a world-class customer experience.”
Dan added, “I am really eager to join the TrialScope team. We are poised to make an incredible and lasting impact on the clinical trial disclosure market. We have a strong and loyal customer base and some truly exciting product development plans. That combination is a strong foundation for continued growth. I look forward to contributing to such an accomplished team.”
Dan will be based in TrialScope’s headquarters offices in Jersey City, New Jersey.
About TrialScope
TrialScope, recognized in CIOReview’s 2016 List of the 20 Most Promising Pharma and Life Sciences Tech Solution Providers, and the 2016 HealthCare & Pharmaceuticals Awards, simplifies the complexities of clinical trial transparency. TrialScope’s award-winning, proven solutions have been implemented successfully and rigorously tested in the most complex environments and are managing disclosures for roughly 30% of industry sponsored clinical trials. The company’s market-driven solutions and expertise enable sponsors to improve performance, mitigate compliance risk, and ultimately optimize efficiencies with clinical content lifecycle management tools, expertise and processes. TrialScope technologies are offered via a validation-ready SaaS platform hosted in a private cloud.
CONTACT: Alyson Kuritz, 908-892-7149, alyson@0to5.com
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/trialscope-appoints-new-vice-president-of-business-development-300343060.html
SOURCE TrialScope
